Assessment of Generalizability Methods to Extend Phase III Clinical Trial Effect Estimates in the Non-Squamous Metastatic NSCLC Population
M Sbirnac - 2023 - tspace.library.utoronto.ca
Generalizability methods may be used to estimate the population average treatment effect
(PATE) of clinical trial therapeutics. However, few studies have applied those methods for …
(PATE) of clinical trial therapeutics. However, few studies have applied those methods for …